We are delighted to once again take part in the Swiss Biotech Day on 5 and 6 May. As a pharmaceutical consulting firm with a Swiss base in Basel, we are proud to be a member of the prestigious Swiss Biotech Association.
Our programme this year includes attending selected events and panel discussions:
May 4, 17:30 – 20:30 | Welcome Reception
May 5, 10:00 – 11:00 | Swiss Biotech Association General Assembly
May 5, 15:30 – 16:15 | How to reach more patients faster: the promise of international collaboration and shared regulatory approval pathways
| Name | Position | Institution |
|---|---|---|
| Eveline Trachsel | Head of Medicinal Product Authorisation and Vigilance | Swissmedic, Swiss Agency for Therapeutic Products |
| Name | Position | Institution |
|---|---|---|
| Corinne Wenger | Head of Regulatory Affairs | Roche Pharma (Schweiz) AG |
| Sabine Ledderhose | Head of Regulatory Affairs | Astra Zeneca |
| Sergio Cantoreggi | Chief Scientific Officer | Sintetica S.A. |
May 5, 17:30 – 18:15 | Enhancing Europe’s Role as a Global Hub for Oncology Trials
| Name | Position | Institution |
|---|---|---|
| Rute Marques | CEO | ROK Communications |
| Name | Position | Institution |
|---|---|---|
| Pilar de la Rocha Mur | Head of Clinical Operations, EMEA | BeiGene |
| Dr. Anna Maria Frustaci | ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Milan, Italy | |
| David Alsadius | Solid Tumor Franchise Lead | IQVIA |
May 6, 15:00 – 15:45 | Radioligand Therapies – Opportunities and Challenges for Switzerland and Globally
| Name | Position | Institution |
|---|---|---|
| Philippe Legenne | CMO | Molecular Partners |
| Name | Position | Institution |
|---|---|---|
| Melpomeni Fani | Head of Radiopharmaceutical Chemistry | University Hospital Basel |
| Sibylle Jennings | Global Regulatory Team Lead – Radiosensitive Cancers | Novartis |
| Emanuele Ostuni | CEO | ARTBIO |
| Arnaud Lesegretain | CEO | Orano Med |
May 6, 16:00 – 16:45 | From Innovation to Patient: Swissmedic’s Role in Accelerating Drug Development and Patient Access
| Name | Position | Institution |
|---|---|---|
| Eliane Schmid | Head of Communication | Swissmedic, Swiss Agency for Therapeutic Products |
| Name | Position | Institution |
|---|---|---|
| Benoît Dubuis | President | Fondation INARTIS |
| Laura Andrea Wyss | Associate Director Regulatory Strategy | Moderna Switzerland |
| Sandra Zaugg | Head Division Regulatory Assessment | Swissmedic |
| Julia Djonova | Head of Division Advanced Therapy Medicinal Products | Swissmedic |
| Deana Mohr | Project Leader | MUVON Therapeutics, ETH Zürich |
We look forward to engaging with esteemed international experts in the biotechnology sector.
